IBA Launches MaxiPRO, an Innovative Rental Solution That Makes Proton Therapy More Accessible to Cancer Patients Everywhere

LOUVAIN-LA-NEUVE, Belgium--(Business Wire)--
IBA (Ion Beam Applications S.A.) announces today the launch of MaxiPRO Rental
for Proton Therapy centers, which will enable significantly more hospitals and
cancer centers to make Proton Therapy available for their cancer patients.

"Until now, the complexity of financing a Proton Therapy center and the delay
between capital expenditures and revenue generation were major impediments for
our customers that wanted to make Proton Therapy accessible for their patients",
said Jean-Marc Andral, President of IBA Proton Therapy business. "With MaxiPRO,
IBA proposes a "one stop shop" offering for a Proton Therapy center designed
specifically for our clients` needs of size, configuration and affordability,
that literally equates to "No Pay until Opening Day."

MaxiPRO is an all-inclusive rental offering that makes a fully operational
Proteus Proton Therapy system available to qualified clients against a
pre-determined monthly fee.

This fee may cover the Proteus system, its installation, ancillary systems, the
building, and the operation and maintenance of the equipment, or any part of the
above, over an agreed upon period of time.

By adopting this solution, IBA customers will be able to provide Proton Therapy
to their patients:

* With one single partner.
* With greater facilitation and speed in the decision process.
* Without any payment before the center is operational.
* With a match between start of monthly fee payments and start of revenue
generation.

"IBA has built its success on its leadership in technology innovation and
operational excellence. We are proud to extend this leadership to financing,
which facilitates the acquisition process for our clients even further, so that
they can concentrate on the clinical aspects of the management of the PT center
while IBA takes care of the rest. My hope is that MaxiPRO will accelerate access
to Proton Therapy technology and hence make this highly precise cancer treatment
available for more and more patients in the near future," says Pierre Mottet,
Chief Executive Officer of IBA.

MaxiPRO Rental is one of several financial offerings that IBA makes available to
its customers. Tailored, structured financing solutions are also available to
meet any and all of IBA customers` needs.

Proton Therapy is an advanced alternative to X-ray radiation therapy for certain
types of cancerous and non-cancerous tumors. Proton Therapy has excellent dose
distribution, depositing the majority of its energy within a precisely
controlled range, directly within the tumor, sparing surrounding healthy
tissues. Higher doses can be delivered to the tumor without increasing the risk
of side effects and long-term complications, improving outcomes and quality of
life for patients.

About IBA

IBA develops and markets leading edge technologies, pharmaceuticals and
tailor-made solutions for healthcare with a focus on cancer diagnosis and
therapy. Leveraging its scientific expertise, IBA is also active in the field of
industrial sterilization and ionization.

Listed on the pan-European stock exchange EURONEXT, IBA is included in the
BelMid Index.

IBA
Bernard Dandoy
Tél : +32 10 47 58 90
Export & Project Finance Director
InvestorRelations@iba-group.com

Copyright Business Wire 2009